Palliative care in hepatocellular carcinoma

Palliative care in hepatocellular carcinoma.

Full text not available from this repository.
Item Type: Review
Status: Published
Official URL:
Journal or Publication Title: Journal of Gastroenterology and Hepatology
Date: 2020
Divisions: Liver Injury and Cancer
Depositing User: General Admin
Identification Number: 10.1111/jgh.15169
ISSN: 0815-9319
Date Deposited: 22 Dec 2020 03:07

Hepatocellular carcinoma is a common cancer with a poor prognosis, associated with high economic costs and a significant burden of disease. While it is often asymptomatic in the early stages, patients may experience great discomfort from advanced disease, treatment adverse effects, or decompensation of underlying cirrhosis. Palliative care has the potential to markedly improve quality of life, physical, and psychological symptoms in patients with end‐stage liver disease, and has been shown to prolong survival in some nonhepatocellular carcinoma malignancies. However, this service is underutilized in hepatocellular carcinoma, and referrals are frequently late due to factors such as stigmatization, inadequate resources, lack of education for nonpalliative care physicians and inadequate modeling for integration of palliative and supportive care within liver disease services. In the future, education workshops, population‐based awareness campaigns, increased funding and improved models of care, may improve the uptake of palliative care and subsequently optimize patient care, particularly towards the end of life.

Laube, Robyn
Sabih, Abdul‐Hamid
Strasser, Simone I
Lim, Lynn
Cigolini, Maria
Liu, Ken
Last Modified: 05 Jan 2021 11:45

Actions (login required)

View Item View Item